Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Applied Optoelectronics
AAOI
$7.57B
| $751K | ﹤0.01% |
+63,200
| New | +$674K |
|
2752
MarineMax
HZO
$759M
| $751K | ﹤0.01% |
+45,000
| New | +$734K |
|
2753
Energy Recovery
ERII
$446M
| $747K | ﹤0.01% |
76,300
-22,900
| -23% | -$211K |
|
2754
Gaia
GAIA
$46.8M
| $742K | ﹤0.01% |
92,900
-38,600
| -29% | -$298K |
|
2755
Lands' End
LE
$370M
| $738K | ﹤0.01% |
43,900
-49,270
| -53% | -$645K |
|
2756
FreightCar America
RAIL
$261M
| $738K | ﹤0.01% |
356,584
+221,300
| +164% | +$664K |
|
2757
iShares Global Tech ETF
IXN
$8.32B
| $737K | ﹤0.01% |
21,012
+14,412
| +218% | +$473K |
|
2758
Lipocine
LPCN
$17.5M
| $732K | ﹤0.01% |
111,839
+76,029
| +212% | +$1.95M |
|
|
KG
2759
Kestrel Group
KG
$69.4M
| $732K | ﹤0.01% |
48,820
+545
| +1% | +$7.31K |
|
|
IFLN
2760
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$308M
| $732K | ﹤0.01% |
38,000
-14,094
| -27% | -$269K |
|
2761
Emerson Radio
MSN
$7.79M
| $731K | ﹤0.01% |
890,950
+4,300
| +0.5% | +$3.69K |
|
2762
Cineverse
CNVS
$56.2M
| $726K | ﹤0.01% |
51,841
+315
| +0.6% | +$5.42K |
|
|
RBNC
2763
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
| $726K | ﹤0.01% |
32,625
+14,600
| +81% | +$329K |
|
2764
FVCBankcorp
FVCB
$335M
| $722K | ﹤0.01% |
51,625
+21,750
| +73% | +$301K |
|
2765
Everest Group
EG
$14.5B
| $721K | ﹤0.01% |
2,605
-27,600
| -91% | -$7.28M |
|
2766
Willamette Valley Vineyards
WVVI
$12.7M
| $717K | ﹤0.01% |
103,502
+5,424
| +6% | +$38K |
|
2767
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$741M
| $715K | ﹤0.01% |
16,300
-5,600
| -26% | -$251K |
|
2768
MaxLinear
MXL
$6.06B
| $715K | ﹤0.01% |
33,713
-16,500
| -33% | -$342K |
|
2769
Companhia Siderúrgica Nacional
SID
$1.31B
| $712K | ﹤0.01% |
206,376
-3,952,500
| -95% | -$12.3M |
|
|
OPTN
2770
DELISTED
OptiNose
OPTN
| $711K | ﹤0.01% |
5,140
+2,447
| +91% | +$317K |
|
|
TRIB
2771
Trinity Biotech
TRIB
$7.83M
| $710K | ﹤0.01% |
4,581
+45
| +1% | +$6.42K |
|
|
IEA
2772
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
| $708K | ﹤0.01% |
219,833
+11,100
| +5% | +$34.4K |
|
|
TBI
2773
Trueblue
TBI
$215M
| $707K | ﹤0.01% |
29,400
-62,600
| -68% | -$1.43M |
|
2774
The Joint Corp
JYNT
$118M
| $704K | ﹤0.01% |
43,588
-27,883
| -39% | -$507K |
|
|
YARW
2775
Yarrow Bioscience, Inc. Common Stock
YARW
$23.4M
| $704K | ﹤0.01% |
42
+7
| +20% | +$117K |
|
Similar funds
Renaissance Technologies's Q4 2019 Portfolio in Review
As of Q4 2019, Renaissance Technologies held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Renaissance Technologies's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Renaissance Technologies's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Renaissance Technologies fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Renaissance Technologies's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Renaissance Technologies opened 518 new positions and closed 443 in Q4 2019.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.